全文获取类型
收费全文 | 217篇 |
免费 | 22篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 12篇 |
2020年 | 6篇 |
2019年 | 5篇 |
2018年 | 11篇 |
2017年 | 9篇 |
2016年 | 6篇 |
2015年 | 18篇 |
2014年 | 14篇 |
2013年 | 22篇 |
2012年 | 19篇 |
2011年 | 16篇 |
2010年 | 12篇 |
2009年 | 6篇 |
2008年 | 5篇 |
2007年 | 7篇 |
2006年 | 7篇 |
2005年 | 9篇 |
2004年 | 3篇 |
2003年 | 4篇 |
2002年 | 6篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 4篇 |
1998年 | 1篇 |
1996年 | 1篇 |
1993年 | 1篇 |
1990年 | 4篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有239条查询结果,搜索用时 46 毫秒
31.
Microsatellites are abundant across prokaryotic and eukaryotic genomes. However, comparative analysis of microsatellites in the organellar genomes of plants and their utility in understanding phylogeny has not been reported. The purpose of this study was to understand the organization of microsatellites in the coding and non-coding regions of organellar genomes of major cereals viz., rice, wheat, maize and sorghum. About 5.8-14.3% of mitochondrial and 30.5-43.2% of chloroplast microsatellites were observed in the coding regions. About 83.8-86.8% of known mitochondrial genes had at least one microsatellite while this value ranged from 78.6-82.9% among the chloroplast genomes. Dinucleotide repeats were the most abundant in the coding and non-coding regions of the mitochondrial genome while mononucleotides were predominant in chloroplast genomes. Maize harbored more repeats in the mitochondrial genome, which could be due to the larger size of genome. A phylogenetic analysis based on mitochondrial and chloroplast genomic microsatellites revealed that rice and sorghum were closer to each other, while wheat was the farthest and this corroborated with the earlier reported phylogenies based on nuclear genome co-linearity and chloroplast gene-based analysis. 相似文献
32.
Aspects on biodiversity and conservation of the ichthyofauna in the Asian region, in comparison to that of Africa, Europe
and North America have been relatively less documented. This paper attempts to evaluate the above aspects in the East, and
South and Southeast Asia based on available information in the literature. The familial diversity in inland waters in Asia
(121 families) is considerably higher than in African and Latin American. Also, the finfish faunal diversity of 21 major river
basins in East, and South and Southeast Asian indicate that species diversity is not necessarily related to familial diversity.
The fish fauna in the region considered presently is highly diverse with an estimated cumulative total of 7447 species. Amongst
the freshwater fishes the dominant groups are cyprinids (Cyprinidae, about 1000 species), loaches (about 400 species) of the
families Balitoridae and Cobitiidae, gobids (Gobiidae, 300 species), catfishes (Bagridae, about 100 species), and the Osphronemidae
(85 species). In the region, 462 freshwater finfish species are reckoned to be threatened, accounting for 17.5% of the all
finfish species in this status in the world. In the region there are 66 species that are critically endangered and/or endangered,
of which 32 are cyprinids, 14 of which are endemic to Lake Lanao, Mindano Island, Philippines. The diversity of freshwater
fish species in the region was significantly related to the land area of the different countries in the following manner:
.
In addition, the fish species diversity in the major river basins of the region was also found to be positively related to
the basin area:
.
Based on above relationship, the predicted fish species richness did not necessarily correlate to river basin size, and rivers
with small basins were shown to have high indices. The paper also attempts to evaluate the reasons affecting fish species
diversity in the region and suggests mitigating measures. 相似文献
33.
Morita YS Sena CB Waller RF Kurokawa K Sernee MF Nakatani F Haites RE Billman-Jacobe H McConville MJ Maeda Y Kinoshita T 《The Journal of biological chemistry》2006,281(35):25143-25155
Phosphatidylinositol mannosides (PIMs) are a major class of glycolipids in all mycobacteria. AcPIM2, a dimannosyl PIM, is both an end product and a precursor for polar PIMs, such as hexamannosyl PIM (AcPIM6) and the major cell wall lipoglycan, lipoarabinomannan (LAM). The mannosyltransferases that convert AcPIM2 to AcPIM6 or LAM are dependent on polyprenol-phosphate-mannose (PPM), but have not yet been characterized. Here, we identified a gene, termed pimE that is present in all mycobacteria, and is required for AcPIM6 biosynthesis. PimE was initially identified based on homology with eukaryotic PIG-M mannosyltransferases. PimE-deleted Mycobacterium smegmatis was defective in AcPIM6 synthesis, and accumulated the tetramannosyl PIM, AcPIM4. Loss of PimE had no affect on cell growth or viability, or the biosynthesis of other intracellular and cell wall glycans. However, changes in cell wall hydrophobicity and plasma membrane organization were detected, suggesting a role for AcPIM6 in the structural integrity of the cell wall and plasma membrane. These defects were corrected by ectopic expression of the pimE gene. Metabolic pulse-chase radiolabeling and cell-free PIM biosynthesis assays indicated that PimE catalyzes the alpha1,2-mannosyl transfer for the AcPIM5 synthesis. Mutation of an Asp residue in PimE that is conserved in and required for the activity of human PIG-M resulted in loss of PIM-biosynthetic activity, indicating that PimE is the catalytic component. Finally, PimE was localized to a distinct membrane fraction enriched in AcPIM4-6 biosynthesis. Taken together, PimE represents the first PPM-dependent mannosyl-transferase shown to be involved in PIM biosynthesis, where it mediates the fifth mannose transfer. 相似文献
34.
Representatives of Ooperipatellus (Peripatopsidae) are among the smallest onychophorans known, commonly varying between 10 and 20 mm in length. Herein, we present a peculiar new species of Ooperipatellus from Tasmania that can exceed twice the length of other representatives of this taxon. Ooperipatellus nickmayeri sp. nov. is comprehensively described based on morphological, molecular, karyological and slime protein profile data. Morphological analyses expose a set of novel features in this species, including a swollen area covered with a modified integument on the posterior border of the male genital pad, modified papillae on the female ovipositor and the presence of pseudoplicae in the dorsal integument. The evolutionary significance of pseudoplicae remains unclear, but similarities between O. nickmayeri sp. nov. and Plicatoperipatus jamaicensis, the only species from which these structures were previously known, suggest they evolved due to functional constraints of the onychophoran integument. Our karyological investigation further revealed that the new species has the largest karyotype known within Peripatopsidae (2n = 50, XY). Finally, the results of our molecular phylogenetic analyses support the recognition of O. nickmayeri sp. nov. and shed light on previously unclear aspects of the biogeographical history of Ooperipatellus in Southern Australia, Tasmania and New Zealand. 相似文献
35.
Zebrafish (Danio rerio) represents a powerful model system in cancer research. Recent observations have shown the possibility to exploit zebrafish to investigate tumor angiogenesis, a pivotal step in cancer progression and target for anti-tumor therapies. Experimental models have been established in zebrafish adults, juveniles, and embryos, each one with its own advantages and disadvantages. Novel genetic tools and high resolution in vivo imaging techniques are also becoming available in zebrafish. It is anticipated that zebrafish will represent an important tool for chemical discovery and gene targeting in tumor angiogenesis. This review focuses on the recently developed tumor angiogenesis models in zebrafish, with particular emphasis to tumor engrafting in zebrafish embryos. 相似文献
36.
Susana Cardoso Cristina Carvalho Ricardo Marinho Anabel Simões Cristina M. Sena Paulo Matafome Maria S. Santos Raquel M. Seiça Paula I. Moreira 《Journal of bioenergetics and biomembranes》2014,46(5):347-355
Advanced glycation end products (AGEs) and methylglyoxal (MG), an important intermediate in AGEs synthesis, are thought to contribute to protein aging and to the pathogenesis of age-and diabetes-associated complications. This study was intended to investigate brain mitochondria bioenergetics and oxidative status of rats previously exposed to chronic treatment with MG and/or with pyridoxamine (PM), a glycation inhibitor. Brain mitochondrial fractions were obtained and several parameters were analyzed: respiratory chain [states 3 and 4 of respiration, respiratory control ratio (RCR), and ADP/O index] and phosphorylation system [transmembrane potential (ΔΨm), ADP-induced depolarization, repolarization lag phase, and ATP levels]; hydrogen peroxide (H2O2) production levels, mitochondrial aconitase activity, and malondialdehyde levels as well as non-enzymatic antioxidant defenses (vitamin E and glutathione levels) and enzymatic antioxidant defenses (glutathione disulfide reductase (GR), glutathione peroxidase (GPx), and manganese superoxide dismutase (MnSOD) activities). MG treatment induced a statistical significant decrease in RCR, aconitase and GR activities, and an increase in H2O2 production levels. The administration of PM did not counteract MG-induced effects and caused a significant decrease in ΔΨm. In mitochondria from control animals, PM caused an adaptive mechanism characterized by a decrease in aconitase and GR activities as well as an increase in both α-tocopherol levels and GPx and MnSOD activities. Altogether our results show that high levels of MG promote brain mitochondrial impairment and PM is not able to reverse MG-induced effects. 相似文献
37.
Dai Nagakubo Mitsuyuki Shirai Yuki Nakamura Noriyuki Kaji Chika Arisato Sena Watanabe Ayami Takasugi Fumitoshi Asai 《Comparative medicine》2014,64(2):121-127
The objective of this study was to investigate the effects of liraglutide, an analog of human glucagon-like peptide 1 (GLP1), on WBN/Kob-Leprfa (fa/fa) rats, which spontaneously develop type 2 diabetes mellitus with pancreatic disorder and obesity. Male fa/fa rats (age, 7 wk) were allocated into 4 groups and received liraglutide (37.5, 75, 150 μg/kg SC) or saline (control group) once daily for 4 wk. All rats in the control group became overweight and developed hyperglycemia as they aged. Although the rats given liraglutide showed a dose-dependent reduction in food intake, no significant effects on body weight or fat content occurred. In the liraglutide groups, the development of hyperglycemia was suppressed, even as plasma insulin concentrations increased in a dose-dependent manner. Intravenous glucose tolerance testing of the liraglutide-treated rats confirmed improvement of glucose tolerance and enhanced insulin secretion. Histologic examination revealed increased numbers of pancreatic β-cell type islet cells and increased proliferation of epithelial cells of the small ducts in the liraglutide-treated groups. Although our study did not reveal a significant decrease in obesity after liraglutide administration, the results suggest a marked antidiabetic effect characterized by increased insulin secretion in fa/fa rats with pancreatic disorders.Abbreviations: GLP1, glucagon-like peptide-1; IVGTT, intravenous glucose tolerance testing; T2DM, type 2 diabetes mellitusThe number of patients diagnosed with diabetes has more than doubled over the last 30 y, and diabetes has become an important public health concern worldwide.6 Approximately 90% of patients with diabetes are diagnosed with type 2 diabetes mellitus (T2DM).31 The onset of T2DM is determined by multiple factors that lead to reduced insulin secretion or insulin resistance, including genetic predisposition and lifestyle-associated habits such as lack of exercise, overeating, and obesity. Many drugs are already used clinically to treat T2DM;9,11 nevertheless, the search and development of more efficient and safe drugs is currently underway. In this regard, incretin has recently gained attention as a member of a class of drugs used to treat T2DM.9,11Enteroendocrine cells secret incretin hormones, which augment glucose-induced insulin secretion in response to food ingestion, in a glucose-dependent manner. Currently, the 2 confirmed incretins are glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 (GLP1). Research has shown that GLP1 derivatives have functions in addition to the promotion of insulin secretion, including facilitation of β-cell proliferation,28 suppression of β-cell apoptosis,12 and promotion of β-cell differentiation or de novo formation of β cells.29,30 GLP1 derivatives have been reported to have multiple nonpancreatic functions, including suppression of appetite and body weight,7,13 suppression of gastric secretions,19 reduction of lipid accumulation in the liver,17 and promotion of sensitivity to insulin in adipose cells and skeletal muscle.8,22WBN/Kob-type male rats are a relevant animal model for diabetes without obesity. These rats typically show disease conditions including chronic pancreatitis and pancreatic endocrine disorders.18,26 A new model rat for diabetes was established recently by crossing rats carrying the Leprfa obesity gene with wild-type WBN/Kob rats, yielding a fa/fa congenic strain.1 The obesity gene (Leprfa) is a spontaneous mutation derived from Zucker-fatty rats that leads to dysfunction of the leptin receptor. Rats homozygous for this gene are obese, resistant to insulin, and hyperinsulinemic.4,16,32 Male WBN/Kob-Leprfa rats (hereafter referred to as fa/fa rats) represent a new animal model in which the animals spontaneously develop diabetes in addition to endogenous insulin resistance. Compared with the parental strains, fa/fa rats are characterized by an earlier onset of diabetes and more severe pancreatic complications.1,2 Our previous investigations have revealed that fa/fa rats present with hyperinsulinemia at a prediabetic stage as a compensatory response to insulin resistance, but these rats show high blood glucose levels because of a difficulty in maintaining blood insulin concentrations as a consequence of declining pancreatic β-cell function associated with advancing age.14In the current study, to further validate fa/fa rats as a T2DM model, we investigated the effects of a GLP1 analog in fa/fa rats with hyperglycemia (age, 7 to 11 wk). We used liraglutide, a human GLP1 analog, which has been shown to be clinically effective in T2DM patients.9,11 相似文献
38.
Anny Fortin Diana P. Caridha Susan Leed Franklyn Ngundam Jenell Sena Tom Bosschaerts Sandi Parriott Mark R. Hickman Thomas H. Hudson Max Grogl 《PLoS neglected tropical diseases》2014,8(9)
Background
Cutaneous leishmaniasis (CL) represents a range of skin diseases caused by infection with Leishmania parasites and associated with tissue inflammation and skin ulceration. CL is clinically widespread in both the Old and New World but lacks treatments that are well tolerated, effective and inexpensive. Oleylphosphocholine (OlPC) is a new orally bioavailable drug of the alkylphosphocholine family with potent antileishmanial activity against a broad range of Leishmania species/strains.Methodology/principal findings
The potential of OlPC against Old World CL was evaluated in a mouse model of Leishmania (L.) major infection in BALB/c mice. Initial dose-response experiments showed that an oral daily dose of 40 mg/kg of OlPC was needed to impact time to cure and lesion sizes. This dose was then used to directly compare the efficacy of OlPC to the efficacy of the antileishmanial drugs miltefosine (40 mg/kg/day), fluconazole (160 mg/kg/day) and amphotericin B (25 mg/kg/day). OlPC, miltefosine and fluconazole were given orally for 21 days while amphotericin B was administered intraperitoneally for 10 days. Ulcer sizes and animal weights were followed up on a weekly basis and parasitemia was determined by means of a real-time in vivo imaging system which detects luminescence emitted from luciferase-expressing infecting L. major parasites. Amphotericin B and OlPC showed excellent efficacy against L. major lesions in terms of reduction of parasitic loads and by inducing complete healing of established lesions. In contrast, treatment with miltefosine did not significantly affect parasitemia and lesion sizes, while fluconazole was completely ineffective at the dose regimen tested.Conclusions/Significance
Given the data showing the outstanding efficacy and tolerability of OlPC, our results suggest that OlPC is a promising new drug candidate to improve and simplify current clinical management of L. major CL. 相似文献39.
Ramon Guerra de Oliveira Fabiana Sélos Guerra Cláudia dos Santos Mermelstein Patrícia Dias Fernandes Isadora Tairinne de Sena Bastos Fanny Nascimento Costa 《Journal of enzyme inhibition and medicinal chemistry》2018,33(1):1181-1193
In this study, we synthesized a new congener series of N-sulphonylhydrazones designed as candidate ROCK inhibitors using the molecular hybridization of the clinically approved drug fasudil (1) and the IKK-β inhibitor LASSBio-1524 (2). Among the synthesized compounds, the N-methylated derivative 11 (LASSBio-2065) showed the best inhibitory profile for both ROCK isoforms, with IC50 values of 3.1 and 3.8?µM for ROCK1 and ROCK2, respectively. Moreover, these compounds were also active in the scratch assay performed in human breast cancer MDA-MB 231 cells and did not display toxicity in MTT and LDH assays. Molecular modelling studies provided insights into the possible binding modes of these N-sulphonylhydrazones, which present a new molecular architecture capable of being optimized and developed as therapeutically useful ROCK inhibitors. 相似文献
40.
Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool,CD44 targeted based,of glioblastoma multiforme 下载免费PDF全文